Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

(2020) Sundy N.Y. Yang et al.   ANTIVIRAL RESEARCH

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

The COVID‐19 epidemic

(2020) Thirumalaisamy P. Velavan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China

(2020) Rossella Porcheddu et al.   Journal of Infection in Developing Countries

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

(2020) Xiaobo Yang et al.   Lancet Respiratory Medicine

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China

(2020) Yan Deng et al.   CHINESE MEDICAL JOURNAL

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

(2020) Xueting Yao et al.   CLINICAL INFECTIOUS DISEASES

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

(2020) Rong-Hui Du et al.   EUROPEAN RESPIRATORY JOURNAL

Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

(2020) Ming Zhao   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin

(2020) Alberto Cipriani et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The SARS-CoV-2 outbreak: What we know

(2020) Di Wu et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020) Joshua Geleris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

(2020) Jianjun Gao et al.   BioScience Trends

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

(2020) Khan Sharun et al.   Annals of Clinical Microbiology and Antimicrobials

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

(2020) Wei Tang et al.   BMJ-British Medical Journal

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

(2020) Ren Mao et al.   Lancet Gastroenterology & Hepatology

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

(2020) Leon Caly et al.   ANTIVIRAL RESEARCH

COVID-19, SARS and MERS: are they closely related?

(2020) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

(2020) Fatemeh Heidary et al.   JOURNAL OF ANTIBIOTICS

Risk Factors for Mortality in Patients with COVID-19 in New York City

(2020) Takahisa Mikami et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

(2020) Qing Ye et al.   JOURNAL OF INFECTION

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

(2020) Alexandre B. Cavalcanti et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 viral load predicts COVID-19 mortality

(2020) Elisabet Pujadas et al.   Lancet Respiratory Medicine

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

(2020) Jacek Baj et al.   Journal of Clinical Medicine

Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus

(2018) Tie-Long Xu et al.   PLoS Neglected Tropical Diseases

Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers

(2018) Lara Kern et al.   Cancers

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

(2016) Nicholas J. Barrows et al.   Cell Host & Microbe

Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import

(2016) Veronika Götz et al.   Scientific Reports

Ivermectin inhibits porcine reproductive and respiratory syndrome virus in cultured porcine alveolar macrophages

(2015) Yoo Jin Lee et al.   ARCHIVES OF VIROLOGY

The role of adipose tissue immune cells in obesity and low-grade inflammation

(2014) Milos Mraz et al.   JOURNAL OF ENDOCRINOLOGY

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

(2012) Kylie M. Wagstaff et al.   BIOCHEMICAL JOURNAL

Dynamics of a Cytokine Storm

(2012) Hao Hong Yiu et al.   PLoS One

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES